NRIX
Nurix TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
NRIX vs peer average
28/100
NRIX vs. peer average (F vs. D)
Grade spread
A 1 · B 1 · C 2 · D 4 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
CLDX is the first available peer comparator.
Celldex is the closest market-cap clinical-stage biotech comparator in the candidate set: valuation is also heavily event-driven by trial updates and regulatory path clarity rather than current product revenue.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NRIX
Nurix Therapeutics
CLDX
Celldex Therapeutics
Grade
F
C
Momentum
79
16
Value
41
41
Sentiment
26
73
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs CLDX
NRIX / CLDX
Grade Position
Below peers
NRIX vs. peer average (F vs. D)
28/100
Momentum
79
NRIXValue
41
NRIXSentiment
26
CLDXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NRIX
CLDX is the first peer returned for this comparison set.